As of 2026-01-07, the Relative Valuation of Revolution Medicines Inc (RVMD) is (46.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 79.85 USD, the upside of Revolution Medicines Inc based on Relative Valuation is -158.1%.
The range of the Relative Valuation is (28.28) - (53.88) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.8x - 20.8x | 17.8x |
| Forward P/E multiples | 10.9x - 25.4x | 18.1x |
| Fair Price | (28.28) - (53.88) | (46.40) |
| Upside | -135.4% - -167.5% | -158.1% |
| Date | P/E |
| 2026-01-06 | -30.89 |
| 2026-01-05 | -30.30 |
| 2026-01-02 | -30.57 |
| 2025-12-31 | -30.81 |
| 2025-12-30 | -30.82 |
| 2025-12-29 | -31.15 |
| 2025-12-26 | -31.24 |
| 2025-12-24 | -31.41 |
| 2025-12-23 | -31.05 |
| 2025-12-22 | -31.17 |
| 2025-12-19 | -30.47 |
| 2025-12-18 | -29.38 |
| 2025-12-17 | -29.68 |
| 2025-12-16 | -30.00 |
| 2025-12-15 | -30.56 |
| 2025-12-12 | -30.53 |
| 2025-12-11 | -30.37 |
| 2025-12-10 | -30.13 |
| 2025-12-09 | -30.10 |
| 2025-12-08 | -30.97 |
| 2025-12-05 | -30.81 |
| 2025-12-04 | -30.36 |
| 2025-12-03 | -30.05 |
| 2025-12-02 | -29.13 |
| 2025-12-01 | -29.32 |
| 2025-11-28 | -30.08 |
| 2025-11-26 | -30.01 |
| 2025-11-25 | -29.52 |
| 2025-11-24 | -28.49 |
| 2025-11-21 | -27.41 |
| 2025-11-20 | -27.03 |
| 2025-11-19 | -27.28 |
| 2025-11-18 | -27.30 |
| 2025-11-17 | -26.74 |
| 2025-11-14 | -26.21 |
| 2025-11-13 | -24.90 |
| 2025-11-12 | -25.46 |
| 2025-11-11 | -24.79 |
| 2025-11-10 | -24.26 |
| 2025-11-07 | -23.60 |
| 2025-11-06 | -23.74 |
| 2025-11-05 | -22.95 |
| 2025-11-04 | -22.66 |
| 2025-11-03 | -22.95 |
| 2025-10-31 | -22.76 |
| 2025-10-30 | -22.77 |
| 2025-10-29 | -22.44 |
| 2025-10-28 | -22.50 |
| 2025-10-27 | -22.43 |
| 2025-10-24 | -21.07 |